Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- UNFI +6.4%, PCYG +5.5%, LAKE +4.3%
M&A news:
- ALV +9.5% (initiates strategic review with the intent to create separate companies of its current business segments, Passive Safety and Electronics)
- THC +7.8% (WSJ reporting the company is considering sale; Glenview confirms plans to engage with the Board in connection with the CEO transition and search/Board refreshment)
Other news:
- HALO +19.1% (HALO and BMY enter collaboration/license agreement to develop Bristol-Myers Squibb medicines using Halozyme's ENHANZE technology)
- RETA +5.1% ( confirms it received orphan drug designation for omaveloxolone for the treatment of malignant melanoma )
- AAC +3% (ticking higher-to increase payor and geographic diversification with agreement to acquire AdCare in New England )
- CYH +2.9% (higher with THC)
- RDUS +2.4% ( slightly higher after 10% owner Biotech Growth disclosed purchase of another 50K shares)
- SALT +2.2% (authorized the repurchase of up to $50.0 million of the Company's common stock in open market or privately negotiated transactions)
- PLUG +1.7% (in sympathy with BLDP)
- HCA +1.3% (higher with THC)
- FCAU +1.3% (reports European sales increased 9.8% in Aug)
- BLDP +1.1% (accepted Letter of Intent to provide FCveloCity-HD 100-kilowatt fuel cell engines to power 8 ExquiCity tram-buses being built by Van Hool NV during the second half of 2019), .
Analyst comments:
- RARE +4% (upgraded to Outperform from Neutral at Wedbush)
- NUE +1.4% (upgraded to Buy from Neutral at Citigroup)